The head of the EU’s pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, modelled after the US Nasdaq, to help retain biotech innovation and investment within the region.
The head of the EU’s pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, modelled after the US Nasdaq, to help retain biotech innovation and investment within the region.